About Conference

Tracks/Sessions

Track 1: Artificial Intelligence in Drug Discovery

The identification and development of new pharmaceuticals is being greatly accelerated by artificial intelligence (AI), which is transforming the field of drug research and discovery process. Artificial intelligence (AI) algorithms can evaluate large quantities of biological, chemical, and clinical data much more quickly and correctly than traditional methods, especially those that use machine learning and deep learning. With the aid of these technologies, medication interactions may be predicted, drug design can be optimized, and possible adverse effects can be more accurately identified. As a result, AI is speeding up the process of finding new therapeutic options and cutting down on the expenses and lead times involved in introducing new medications to the market.

• Target identification and validation
• Simulation of drug-drug interactions
• Adverse event prediction

Track 2: Digital Health and Telemedicine

By utilizing technology to improve accessibility and patient care, digital health and telemedicine represent revolutionary developments in the healthcare industry. A wide range of technologies, such as wearables, mobile health apps, and electronic health records, are included in digital health. These technologies allow for more individualized treatment and ongoing health monitoring. Contrarily, telemedicine makes it possible for patients and medical professionals to consult remotely via video chats, eliminating the need for in-person visits and increasing access to care, particularly in underprivileged areas. When taken as a whole, these advances are leading to better patient outcomes, more convenience, and increased delivery efficiency in healthcare.

• Telepathology and telepsychology
• Digital therapeutics
• Telehealth platforms
• Remote patient monitoring

Track 3: COVID-19 and Drug Repurposing

COVID-19 has expedited research on drug repurposing, a method that entails repurposing current pharmaceuticals. This strategy has proven invaluable throughout the pandemic since it makes use of well-known medications to promptly meet urgent requirements. Drugs that were initially designed for other illnesses, such as remdesivir and dexamethasone, have been proven to have therapeutic benefits for COVID-19 patients. Repurposing medications can lead to treatment more quickly than creating new ones from scratch. It also makes use of pre-existing safety data, which is important for responding to quickly changing health emergencies.

• Mechanisms of drug repurposing
• Clinical trials and evidence
• Drug candidates for COVID-19

Track 4: Advanced Drug Delivery Systems

The way drugs are given and absorbed by the body is being revolutionized by advanced drug delivery systems (ADDS). These systems use state-of-the-art technologies for drug delivery in a more focused and controlled way, thereby maximizing treatment efficacy and minimizing side effects. Technological advancements like nanotechnology allow for the creation of nanoparticles that can target diseased cells specifically, while microneedle patches provide a non-invasive, painless substitute for injections. Furthermore, responsive materials are used in smart medication delivery systems, which release pharmaceuticals in reaction to particular physiological situations. These developments not only improve therapeutic results but also open the door to more effective and individualized treatment plans.

• Nanotechnology in drug delivery
• Oral drug delivery systems

Track 5: Biologics and Biosimilars

Large, complex pharmaceuticals called biologics are made from living things and are used to treat a variety of ailments, such as cancer, autoimmune diseases, and chronic illnesses. They consist of gene treatments, vaccinations, and monoclonal antibodies. When the patent on the original biologic expires, biosimilars—very identical versions of the biologic—are designed to provide more economical treatment options. Biosimilars, in contrast to small-molecule generics, are required to exhibit comparable safety, efficacy, and quality to the reference biologic; yet, because biologics are inherently variable, they are not interchangeable. The creation of biosimilars offers chances and difficulties for increasing access to necessary treatments while upholding strict criteria for patient safety and effectiveness.

• Immunogenicity
• Comparative clinical trials
• Manufacturing and quality control

Track 6: Pharmacovigilance and Drug Safety

Pharmacovigilance and drug safety are essential elements of the pharmaceutical industry. In order to identify potential safety concerns and reduce risks, pharmacovigilance entails the systematic collection, analysis, and assessment of adverse drug reactions (ADRs). Pharmacovigilance assists in the detection of uncommon or chronic side effects that would not have been noticeable during clinical trials by regularly assessing the safety profile of medications. In addition to safeguarding patients, this proactive strategy improves the general caliber and effectiveness of therapeutic interventions. Novel developments in data analytics, real-time monitoring, and regulatory frameworks are always being made to guarantee drug safety and enhance the efficacy of pharmacovigilance systems.

• Adverse drug reactions monitoring
• Risk assessment and management
• Pharmacogenomics and personalized medicine

Track 7: Biotechnology and Biopharmaceuticals

Biotechnology and biopharmaceuticals manufacturing and industry are a fast developing field that concentrates on exploiting biological systems and organisms to generate novel medications and therapies. This area of study makes use of methods from molecular biology, cell culture, and genetic engineering to develop novel therapeutics such gene therapies, vaccines, and monoclonal antibodies. Biopharmaceuticals, which are sourced from living cells or organisms, provide individualized and targeted treatment options for a range of ailments, such as autoimmune problems, genetic abnormalities, and malignancies. Biotechnology is changing medicine by opening up new treatment options for diseases that were previously incurable and by enhancing patient outcomes.

• Gene therapy
• Recombinant DNA technology
• Biological drug delivery systems

Track 8: Wearable Drug Delivery Systems

Because they enable continuous, real-time medication administration and monitoring, wearable drug delivery systems offer a significant development in customized medicine. These wearable medical gadgets are made to precisely distribute medication doses in response to physiological changes or pre-programmed schedules. Wearable devices can improve therapeutic efficacy and minimize negative effects by adjusting dosages according to the wearer's needs through the integration of sensors and smart technologies. This novel strategy enhances patient comfort and compliance, especially when it comes to controlling chronic illnesses, which eventually results in greater health and a higher standard of living.

• Patch-based systems
• Pump systems
• Infusion systems

Track 9: Hydrogel-Based Delivery for Diabetes

Hydrogel-based delivery systems are a possible substitute for daily injections and constitute a substantial improvement in the treatment of diabetic Mellitus. This device delivers prolonged release of GLP-1 receptor agonists, which are essential for controlling blood glucose levels, using a biomimetic hydrogel depot. These injections, which might last for months and are made to fit with regular medical check-up schedules, lessen the burden of treatment on patients. This approach is more effective than daily injections at improving blood glucose control and weight control in laboratory rats, according to preliminary studies. The technology's versatility implies that it might be utilized for other therapeutic proteins and therapies, with the potential to revolutionize diabetes control and other related fields.

• Synthetic hydrogels
• Natural hydrogels

Track 10: Rational Drug Design and Molecular Modeling

Rational drug design and molecular modeling are integral components of modern drug discovery. Rational drug design involves the deliberate creation of new medications based on the knowledge of biological targets. It uses insights into the structure and function of target molecules, such as proteins or enzymes, to design compounds that specifically interact with these targets to elicit a desired therapeutic effect. Molecular modeling complements this approach by utilizing computational techniques to simulate and visualize the interactions between drugs and their targets at the molecular level. Through techniques like molecular docking, virtual screening, and quantitative structure-activity relationship (QSAR) analysis, scientists can predict the binding affinity and efficacy of drug candidates, streamline the drug discovery process, and enhance the development of more effective and selective therapeutics.

• Structure-based drug design
• Ligand-based drug design
• Computational chemistry

Track 11: Targeted Drug Delivery and Controlled Release Systems

Advanced pharmaceutical technologies such as controlled release systems and targeted drug therapy are intended to improve the safety and effectiveness of treatments. Targeted drug delivery system minimizes exposure to healthy areas and lessens negative effects by directing medication selectively to sick cells or tissues. Numerous methods, including liposomes, nanoparticles, and ligand-receptor interactions, can do this. Contrarily, controlled release systems are designed to release medications at a precise rate, preserving the best possible therapeutic doses for longer. To ensure sustained release, these systems can make use of hydrogels, microspheres, and biodegradable polymers. When combined, these technologies maximize therapeutic impact while minimizing side effects and dosage frequency, leading to improved treatment outcomes.

• Polymeric drug delivery systems
• Lipid-based drug delivery systems
• Implantable drug delivery systems

Track 12: Epigenetic Therapies in Cancer

Targeting the reversible changes to DNA and histones that control gene expression without changing the underlying genetic coding, epigenetic treatments promise a promising new avenue in the cancer diagnosis. Through the reversal of abnormal epigenetic modifications including DNA methylation and histone acetylation, these medicines seek to restore normal gene function in cancer cells. Medication such as histone deacetylase inhibitors and DNA methyltransferase inhibitors suppresses oncogenes or reactivates tumor suppressor genes, changing the behavior of cancer cells and enhancing therapy results. These treatments present the possibility of more accurate and successful interventions as our knowledge of epigenetic pathways grows, improving the capacity to target and treat a variety of tumors with fewer adverse effects.                                                    

• DNA methylation inhibitors
• Epigenetic biomarkers for cancer
• Combination therapies with epigenetic agents

Track 13: Clinical and Hospital Pharmacy

The goal of clinical and hospital pharmacy is to optimize pharmaceutical utilization in healthcare environments through a variety of strategies. Clinical pharmacists ensure that drugs are utilized safely and effectively by collaborating closely with healthcare teams to deliver patient-centered care. Medication therapy management, drug interactions, and therapeutic drug monitoring are important subjects. Hospital pharmacy responsibilities include overseeing formulary administration, controlling drug distribution, and making sure rules and regulations are followed. In order to improve pharmaceutical safety and outcomes, both fields place a strong emphasis on patient education, evidence-based procedures, and technology integration. These procedures are essential for enhancing patient care and bolstering the healthcare system as a whole.

• Clinical pharmacy
• Hospital pharmacy
• Patient safety and quality assurance

Track 14: Natural Products and Traditional Medicine

In the search and creation of novel pharmacological drugs, natural products and conventional medicine are essential components. Many contemporary medications have historical roots in natural compounds obtained from plants, animals, and minerals that were employed in conventional medical procedures. In this branch of study, bioactive compounds from these natural sources are isolated, characterized, their mechanisms of action are understood, and their potential for therapeutic use is assessed. Combining modern pharmacology and traditional medicine can result in novel therapeutics, improve the efficacy and safety of prescription medications, and offer comprehensive medical care. In order to guarantee the safe and efficient use of natural products, thorough scientific validation is becoming increasingly crucial as interest in complementary and alternative medicine rises globally.

• Herbal medicine and phytotherapy
• Marine and microbial natural products
• Traditional medicine systems

Track 15: 3D Printing of Drugs

The ability to create customized medication through 3D printing is a cutting-edge technology that is altering the pharmaceutical production industry. With this novel method, active compounds and excipients can be precisely layered to create personalized dosage forms that are suited to the needs of each patient. Complex drug release profiles, polypills (a pill containing many drugs), and quick prototyping of novel drug formulations are all made possible by 3D printing. Additionally, the technology makes it possible to produce dose forms with precise dimensions and features, which improves patient compliance and treatment effectiveness. Personalized medicine could be revolutionized by 3D printing, which provides unparalleled customization and versatility.

• Polymers and biopolymers
• Selective laser sintering
• Inkjet printing

Track 16: Pharmaceutical Microbiology and Biotechnology

Biotechnology and pharmaceutical microbiology are important domains in the creation of novel treatments and pharmaceuticals. The field of pharmaceutical microbiology is concerned with the function of microbes in the manufacturing of drugs, maintaining product quality, and preventing contamination. This covers research on microbiological pathogens, resistance to antibiotics, and the advancement of sterilization methods. On the other side, biotechnology uses biological systems and species to create novel medications and therapies. This area of study includes the development of biopharmaceuticals, including gene treatments, vaccinations, and monoclonal antibodies.

• Antimicrobial agents and resistance
• Vaccine development
• Gene and cell therapy

Track 17: Vaccine Design and Drug Design

Both medication and vaccine design, with their distinct goals and methodologies, are essential elements of contemporary medicine. The goal of vaccine design is to create vaccinations that, via the use of technologies like mRNA, viral vectors, and recombinant proteins, encourage the immune system to identify and fight particular infections. Inducing a protective immune response that wards off illness is the aim. On the other hand, drug designing entails developing biologics or small molecules that interact with particular biological targets in order to treat or cure illnesses. This procedure entails analyzing structure-activity connections, improving molecules through medicinal chemistry, and customizing medications for maximum safety and efficacy.

• Immunogenicity and safety
• Vaccine delivery systems
• Formulation development

Track 18: Clinical Research & Clinical Trials

Clinical trials and clinical research are vital to medical science because they assess novel medications, medical equipment, and treatment regimens for safety, effectiveness, and best practices. Phase I trials are small-scale trials that evaluate safety first. Phase II and III trials are larger trials that evaluate efficacy and track side effects. Phase IV post-marketing studies are the last stage of this rigorous process that collects additional data on risks, benefits, and long-term effects. Clinical trials are done under strict regulatory requirements and are carefully designed to achieve the highest levels of scientific integrity and ethics. Producing trustworthy data that can support the approval of novel treatments, enhance patient outcomes, and advance public health is the ultimate aim of clinical research.

• Clinical trial design and methodology
• Patient recruitment and retention
• Ethics and regulatory compliance

Track 19: Pharmacogenetics & Pharmacogenomics

At the nexus of pharmacology and genetics are the studies of pharmacogenetics and pharmacogenomics, which study how individual responses to medications are influenced by genetic variants. By customizing therapies to individual genetic profiles, pharmacogenetics aims to maximize therapeutic efficacy and minimize side effects by analyzing how unique gene variants impact an individual's response to specific pharmaceuticals. A more comprehensive method called pharmacogenomics looks at how a person's entire genetic makeup interacts with drugs, utilizing genomic technologies to forecast drug response and identify novel therapeutic targets. When combined, these fields offer the prospect of personalized medicine, in which genetic information is used to tailor treatments, resulting in safer and more successful medical outcomes.

• Genetic variants and drug metabolism
• Adverse drug reactions
• Gene-drug interaction networks

Market Analysis

The pharmaceutical industry (PI) is one of the fastest-growing economic sectors with worldwide sales of more than $1228.45 billion year in 2020. Worldwide revenue in the pharmaceutical market was 1143 billion US dollars in the year of 2017 and it will cross 1462 billion US dollars in 2023. The industry 4.0 of the Pharmaceutical Industry will in the future contribute toward an intelligent automation technology and may support augmented manufacturing, such as a personalized medicine, additive manufacturing, localized 3D printing of treatments etc. In the wake of Covid-19, digitalized technology is more important than ever in allowing firms in all sectors to improve performance through better manufacturing productivity, stronger competitive skills, more accurate planning and forecasting, and financial sustainability

The pharmaceutical grade market is projected to reach USD 183 Million by 2030 at 4.40 % CAGR during the forecast period 2021-2030. Pharmaceutical grade has been used as an excipient for more than a century. Because of its versatility, it is the backbone of many successful formulations. It is produced by concentrating whey or permeate to over-saturate the lactose, then removing, refining, drying, and milling the lactose crystals.

Past Conference Report

PHARMA CONFERENCE 2024

Conference Series is proud to announce The 2^nd Global Pharmaceutical and Pharma Industry Conference, held from April 18-19, 2024, in London, UK, was a monumental event that brought together research experts, professors, research professionals, and policymakers from around the globe. This Conference focused on the theme aiming to address contemporary challenges by sharing cutting-edge research and best practices. The poster sessions were an integral part of PHARMA CONFERENCE 2024, showcasing innovative research conducted by emerging scientists and research professionals. Over 50 posters were presented, covering a wide range of topics. The interactive nature of the poster sessions allowed for fruitful exchanges of ideas and networking opportunities.

PHARMA CONFERENCE 2024 began with an inspiring opening ceremony. The Chair of the Organizing Committee welcomed the attendees and emphasized the importance of advanced techniques. The keynote address was delivered by the most eminent researchers, who highlighted the transformative potential of emerging technologies... PHARMA CONFERENCE 2024 recognized outstanding contributing various awards, like The "Best Poster Presentation" award and The "Young Researcher" award.

Following the success of PHARMA CONFERENCE 2024, we are excited to announce the “8^th International Pharmacy and Pharmaceutical Conference,” scheduled for March 13-14, 2025, in Prague, Czech Republic, with the theme “Pharmacy’s Role in Managing Complex and Rare Diseases."